Real solutions for plaque psoriasis
Plaque psoriasis is the most common form of psoriasis — a chronic, immunologically mediated skin disease. Unlike more acute dermatologic diseases, plaque psoriasis can present more severe symptoms and health risks from comorbidities. Coupled with the mental and emotional strain of the disease, clinical trials can often face challenges ranging from recruitment to patient participation and retention.
With our 15 years of experience in common dermatology disorders and rare diseases, innovative project management, and digital technology, Biorasi executes patient-centric solutions for plaque psoriasis studies:
- Patient-centered strategy manages early interaction with the patient, helping sponsors understand the patient’s mindset, their health status, and what they expect from the trial.
- Integration of our decentralized strategy into the , leveraging telemedicine, home care, and ECOA/ePRO technology to reduce the travel burden and increase enrollment for immunocompromised patients.
- Improved data intelligence for patient-centric trials — giving sponsors access to real-time reporting, facilitating data capture across physical sites and remote visits, and standardizing data to optimize results.
Biorasi Meets First Patient, First Visit Milestone for Dermatology Trial During COVID-19
How Dermatology Research Gaps Represent Untapped Markets for Pharmaceutical Companies
Patient Recruitment Challenges in Dermatology Clinical Trials